Developing a faster and more versatile PCR method for DNA and RNA testing
Official title: Rapid, versatile PCR
Funded at Numentus Technologies INC. · NIH-10822555 · Data updated 2026-11-12
This study is working on a new, faster, and more portable machine to help doctors quickly test for infections like the flu by improving how we copy DNA and RNA, so patients can get their results in just minutes instead of hours.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Numentus Technologies INC. NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | February 21, 2024 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $297,872 |
| NIH project number | 1R43AI181390-01 |
| Project ID | NIH-10822555 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who require rapid diagnostic testing for viral infections, such as influenza.
✕Less likely to help
Patients with conditions that do not require molecular diagnostic testing or those who are not affected by viral infections may not benefit from this research.
What this research studies
This research focuses on improving the Polymerase Chain Reaction (PCR) technique, which is essential for amplifying DNA and RNA sequences. The goal is to create a new PCR instrument that is not only faster but also more versatile and portable than current models. By utilizing advanced optical heating methods, the research aims to reduce the time required for testing from hours to minutes, making it more efficient for diagnosing infections like influenza and other diseases. Patients may benefit from quicker and more accurate diagnostic results, which can lead to timely treatment.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose infections, leading to faster treatment and better patient outcomes.
How similar studies have gone: Previous advancements in PCR technology have shown promise, particularly during the COVID-19 pandemic, indicating that this approach has the potential for success.
Where this research is happening
-
Numentus Technologies INC.
Menlo Park, United States Active
Researchers
- Principal investigator: Faris, Gregory W — Numentus Technologies INC.
- Study coordinator: Faris, Gregory W
Related research
Other NIH-funded projects on the same topics.
-
Multiplexed blood biomarkers for Alzheimer’s disease subtypes
A new test uses many extracellular vesicle signals from blood to help identify different Alzheimer’s subtypes and guide better diagnosis.
-
Analyzing tiny particles from cells for better diagnostics and therapies
This study is exploring a new way to look at tiny particles released by cells that can provide important clues about cancer and infections, with the goal of helping doctors find better ways to diagnose and treat patients.
-
Developing fast imaging techniques to analyze brain tissue for Alzheimer's disease
This study is looking at new ways to take pictures of brain tissue to help doctors better understand and diagnose Alzheimer's disease, so patients can get more accurate and effective treatments.
-
Exploring bacterial outer membrane vesicles for diagnostics and therapies
This study is exploring how tiny bubbles released by bacteria could help us find and treat infections better by looking closely at what’s inside them, making it easier to identify specific bacterial infections.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.